Guaiazulene liposome as well as preparation method and application thereof
By preparing nano-sized guaiacea liposomes, the problems of poor water and alcohol solubility of guaiacea are solved, and its stability and permeability are improved, achieving excellent performance in transparent systems, especially in light Improves stability and skin feel under heat conditions.
Patent Information
- Application Number
- CN202411197136.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-29
- Publication Date
- 2024-11-29
- Estimated Expiration
- 2044-08-29
AI Technical Summary
Guaishou has poor water-soluble and alcohol-soluble, difficult to penetrate skin tissue, and is unstable to light and heat, limiting its bioavailability and transdermal applications.
Using nano-sized guaiacea liposomes, by combining guaiacea, carvanolide, glycerol, liquid oils, phospholipids and stabilizers in specific proportions, and by high shear homogenization and microjet high pressure homogenization Prepared by treatment technology, guaiac liposomes with particle size ≤30nm are formed, improving their stability, permeability and antioxidant properties.
The excellent stability, permeability, antioxidant and soothing properties of Guaifeld liposomes are achieved, improving their application performance in transparent systems, especially in light and thermal conditions, and the retention rate and skin feel.
Smart Images

Figure CN119033623A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of liposome preparation, and specifically relates to guaiazulene liposome and a preparation method and application thereof. Background Art
[0002] Guaiazulene (INCI name: GUAIAZULENE; CAS number: 489-84-9) is a dark blue, viscous oil that is easy to crystallize, so it is also called guaiazulene. It has multiple biological activities, including antioxidant, anti-inflammatory, soothing and anti-cancer properties.
[0003] However, guaiaczulene has poor water and alcohol solubility and cannot penetrate the stratum corneum barrier, making it difficult to reach the skin tissue and be absorbed by the skin target cells, which seriously limits its bioavailability and transdermal application. In addition, guaiaczulene is also unstable to light and heat. It can be oxidized by oxygen in the air at room temperature, and the oxidation process will be accelerated under light conditions to form a variety of by-products, further limiting its application in transparent systems.
[0004] A Chinese patent with prior art publication number CN117547486B discloses a method for protecting an oil-soluble active ingredient. The technical solution is to improve the compatibility between guaiaczulene and aqueous solution and other components by using polysorbate-80 and ethanol solvent, thereby encapsulating guaiaczulene to form a stable system that is not easily affected by activity, thereby improving the active effect of guaiaczulene absorbed by the skin. However, the technical solution obtains a micron-sized emulsion, which inevitably has problems of poor transparency, poor skin feel and poor permeability.
[0005] Nanoliposomes are composed of phospholipids, and their unique hydrophilic and hydrophobic properties can effectively load hydrophilic active ingredients into the hydrophilic core cavity, and encapsulate hydrophobic active ingredients into the hydrophobic phospholipid bilayer to improve the solubility and bioavailability of active ingredients. In addition, the lipid bilayer nanostructure of nanoliposomes can also enhance the overall skin stratum corneum penetration effect to promote transdermal penetration. Therefore, in theory, nano-scale guaiacyl liposomes have better transparency, skin feel and permeability than micron-scale guaiacyl liposomes.
[0006] The applicant has previously studied the preparation method of ultra-nano liposomes, and disclosed in the Chinese patent publication number CN118286155A that a specific homogenization treatment is used: the "ultra-high pressure homogenization-micro-jet homogenization" micro-mixing reaction process technology has high mixing efficiency and mixing performance. When performing the preparation of nano-inclusions, the particle size of the final product can be reduced to less than 30nm.
[0007] However, the applicant found that the stability, antioxidant properties, permeability and soothing properties of the ultra-nano encapsulation system of guaiacylamine in previous studies could not meet expectations. Based on this, the applicant specially proposed this invention. Summary of the invention
[0008] The present invention aims at solving the problems of poor water solubility, alcohol solubility, permeability, light and heat stability of guaiazulene, and provides a guaiazulene liposome and a preparation method and application thereof. The guaiazulene liposome provided by the present invention has a nanometer size and excellent stability, permeability, antioxidant property, soothing property and skin feel.
[0009] To achieve the above purpose, the technical solution adopted by the present invention is as follows:
[0010] The first aspect of the present invention provides a guaiazulene liposome, the raw materials of which include: glycerol, liquid oil, diol, guaiazulene, phospholipids, tocopherol acetate, kavalactone, stabilizer and purified water.
[0011] Preferably, the guaiazulene liposomes include, by weight, 30-40 parts of glycerol, 20-35 parts of liquid oil, 8-15 parts of glycol, 1-5 parts of guaiazulene, 1-5 parts of phospholipids, 1-2 parts of tocopherol acetate, 0.1-1 parts of kavalactone, 0.005-0.008 parts of stabilizer and 1-35 parts of purified water.
[0012] Preferably, the mass ratio of guaiazulene to kavalactone is 5:1.
[0013] Further preferably, the raw materials of the guaiazulene liposomes include, by mass, 30-35 parts of glycerol, 20-25 parts of liquid oil, 8-10 parts of glycol, 1-5 parts of guaiazulene, 1-2 parts of phospholipids, 1-2 parts of tocopherol acetate, 0.1-1 parts of kavalactone, 0.005-0.008 parts of stabilizer and 29-35 parts of purified water.
[0014] Further preferably, the guaiazulene liposomes include, by mass, 30 parts of glycerol, 20 parts of liquid oils, 9.935 parts of glycols, 5 parts of guaiazulene, 1 part of phospholipids, 1 part of tocopherol acetate, 1 part of kavalactone, 0.0065 parts of stabilizer and 32.0585 parts of purified water.
[0015] Preferably, the liquid fat is triglyceride fat.
[0016] Further preferably, the trilipid oil is selected from at least one of caprylic / capric triglyceride, capric triglyceride, triolein and palmitic triglyceride, and further preferably caprylic / capric triglyceride.
[0017] Preferably, the stabilizer comprises benzotriazolyl dodecyl p-cresol, tris(tetramethylhydroxypiperidinol) citrate, troxerutin and pentaerythritol tetra(di-tert-butylhydroxyhydrocinnamate).
[0018] Preferably, the mass ratio of the benzotriazolyl dodecyl p-cresol, tris(tetramethylhydroxypiperidinol) citrate, troxerutin and pentaerythritol tetra(di-tert-butylhydroxyhydrocinnamate) ester is 0.8-1.2:14-16:2-4:0.8-1.2.
[0019] Further preferably, the mass ratio of the benzotriazolyl dodecyl p-cresol, tris(tetramethylhydroxypiperidinol) citrate, troxerutin and pentaerythritol tetra(di-tert-butyl hydroxyhydrocinnamate) ester is 1:15:3:1.
[0020] Preferably, the phospholipids include natural phospholipids and / or synthetic phospholipids; the natural phospholipids are selected from at least one of hydrogenated lecithin, hydrogenated soybean lecithin, egg yolk lecithin and soybean lecithin; the synthetic phospholipids are selected from at least one of 1-palmitoyl-2-butylphosphatidylcholine, 1-palmitoyl-2-hexanoylphosphatidylcholine, 1-palmitoyl-2-octanoylphosphatidylcholine, 1-palmitoyl-2-decanoylphosphatidylcholine and 1-palmitoyl-2-lauroylphosphatidylcholine.
[0021] Preferably, the diol is selected from at least one of propylene glycol, butylene glycol, 1,2-pentanediol and 1,2-hexanediol, and more preferably propylene glycol.
[0022] Preferably, the particle size of the guaiazulene liposome is ≤30 nm, preferably ≤20 nm.
[0023] Preferably, the particle size distribution index (PDI) of the guaiazulene liposomes is <0.25.
[0024] The second aspect of the present invention provides a method for preparing the above-mentioned guaiazulene liposomes, comprising the following steps: heating and dissolving guaiazulene, kavalactone, liquid oil and tocopherol acetate to obtain phase A; dissolving a stabilizer in a diol to obtain phase B; adding phase B to phase A, and then adding glycerol, phospholipids and purified water and heating to dissolve to obtain phase C; subjecting phase C to high shear homogenization treatment to obtain a micron-sized crude emulsion; and subjecting the micron-sized crude emulsion to microfluidization high-pressure homogenization treatment to obtain guaiazulene liposomes.
[0025] Preferably, the guaiazulene, kavalactone, triglyceride oil and tocopherol acetate are stirred and dissolved in a constant temperature water bath at 30-50°C.
[0026] Preferably, the glycerol, lecithin and purified water are added and stirred to dissolve in a constant temperature water bath at 50-70°C.
[0027] Preferably, the conditions for the high shear homogenization treatment are: a stirring speed of 6000-8000 rpm, and a stirring time of 10-15 min.
[0028] Preferably, the conditions of the microfluidic high-pressure homogenization treatment are: the homogenization pressure is 20000-25000 psi, and the number of times is 1-3 times.
[0029] The third aspect of the present invention provides the use of the above-mentioned guaiazulene liposomes in the preparation of transparent system skin care products, wherein the transparent system skin care products include water-based skin care products and / or essence-based skin care products.
[0030] Compared with the prior art, the present invention has the following beneficial effects:
[0031] 1. The guaiazulene and kavalactone in the present invention improve the stability, permeability, soothing and antioxidant properties of guaiazulene liposomes through synergistic effect, especially when the mass ratio of guaiazulene to kavalactone is 5:1, the effect is best.
[0032] 2. The present invention uses benzotriazolyl dodecyl p-cresol, tris (tetramethyl hydroxypiperidinol) citrate, troxerutin and pentaerythritol tetra (di-tert-butyl hydroxyhydrocinnamate) ester as a protective agent to improve the stability, permeability and antioxidant properties of guaiazulene liposomes.
[0033] 3. The present invention adopts triglyceride oil to improve the skin feel of guaiazulene liposomes. BRIEF DESCRIPTION OF THE DRAWINGS
[0034] Figure 1 This is a transmission electron micrograph of the guaiazulene liposomes of Example 1.
[0035] Figure 2 The particle size, PDI and Zeta potential of the guaiazulene liposomes in Example 1 are shown in FIG.
[0036] Figure 3 The fluorescence microscopy images of tissue sections treated with guaiazulene liposomes in Example 1; A and B represent different parts, respectively. DETAILED DESCRIPTION
[0037] The present invention is further explained below in conjunction with specific embodiments. It should be understood that the specific embodiments described herein are only used to illustrate and explain the present invention, and are not used to limit the present invention.
[0038] In the following examples, unless otherwise specified, all raw materials used were commercially available or prepared by conventional methods in the art.
[0039] The raw material sources of the guaiazulene liposomes in Examples 1-3 and Comparative Examples 1-7 of the present invention are shown in Table 1;
[0040] Table 1
[0041] CAS No. / Source glycerin 56-81-5 Caprylic / capric triglyceride 65381-09-1 Octyldodecanol 5333-42-6 Propylene glycol 57-55-6 Guaichuan 489-84-9 Hydrogenated Lecithin 97281-45-3 Tocopheryl acetate 7695-91-2 Kavalactones 9000-38-8 Ligandrolone 153065-40-8 Benzotriazolyl dodecyl p-cresol 125304-04-3 Tris(tetramethylhydroxypiperidinol) citrate 220410-74-2 Troxerutin 7085-55-4 Pentaerythritol tetrakis(di-tert-butylhydroxyhydrocinnamate) 6683-19-8 Bis-ethylhexyloxyphenol methoxyphenyl triazine 187393-00-6
[0042] The specific formula compositions of the guaiazulene liposomes in Examples 1-3 and Comparative Examples 1-7 of the present invention, in parts by mass, are shown in Table 2:
[0043] Table 2
[0044]
[0045] The method for preparing guaiazulene liposomes of Examples 1-3 comprises the following steps: stirring guaiazulene, kavalactone, caprylic / capric triglyceride and tocopherol acetate in a constant temperature water bath at 40°C until completely dissolved to obtain phase A; dissolving benzotriazolyl dodecyl p-cresol, tris(tetramethylhydroxypiperidinol) citrate, troxerutin and pentaerythritol tetra(di-tert-butyl hydroxyhydrocinnamate) ester in propylene glycol to obtain phase B; adding phase B to phase A, and then adding glycerol, hydrogenated lecithin and purified water to stir and dissolve completely, stirring evenly in a constant temperature water bath at 60°C (stirring time is 5 min, stirring speed is 150 rpm), to obtain phase C; using a homogenizer to perform high shear homogenization treatment on phase C (stirring time is 10 min, stirring speed is
[0046] 8000rpm) to obtain a micron-sized crude emulsion; the micron-sized crude emulsion was subjected to microfluidization high-pressure homogenization (homogenization pressure was 25000psi, times was 2 times) to obtain guaiacyl liposomes.
[0047] Transmission electron microscopy morphology observation of the guaiazulene liposomes of Example 1: A Hitachi HT7800 high-contrast transmission electron microscope was used to observe the surface morphology of the guaiazulene nanoliposomes of Example 1. Before analysis, the guaiazulene nanoliposomes of Example 1 prepared on the first day were diluted to 0.01wt% with ultrapure water of pH 7.0, and 10μL of the diluted guaiazulene nanoliposomes of Example 1 were dropped on a copper mesh. After standing for 2 minutes, excess sample around the copper mesh was aspirated, and then the copper mesh was negatively stained with a 2.0wt% uranyl acetate solution for 5 minutes. Excess staining solution was removed with filter paper, and naturally dried at room temperature. An appropriate amount of sample was dropped on the copper mesh plate, and then photographed and recorded. The results are shown as follows. Figure 1 shown.
[0048] The particle size, PDI and Zeta potential of the guaiazulene liposomes in Example 1 were measured: The average particle size, PDI and Zeta potential of the guaiazulene nanoliposomes in Example 1 were measured using a ZetasizerNano ZSE nanoparticle size analyzer. First, the guaiazulene nanoliposomes in Example 1 prepared on the first day were diluted 100 times with ultrapure water. The test temperature was set to 25°C and the scattering angle was set to 90°. Each sample was scanned 3 times and the average value was taken as the measured value. When measuring the Zeta potential, no dilution was performed and the sample was directly added to the Zeta potential cell for measurement. The results are shown in the figure. Figure 2 shown.
[0049] Depend on Figure 1 and Figure 2 It is concluded that the particle size distribution of the guaiaczulene nanoliposomes in Example 1 is monodisperse, and a relatively low PDI value is maintained when the particle size is small, indicating that the particle size distribution of the guaiaczulene nanoliposomes in Example 1 is relatively uniform, close to a highly aggregated nanodispersion system. The prepared guaiaczulene nanoliposomes in Example 1 are similar to spherical vesicles when observed under a transmission electron microscope, and have a relatively uniform particle size of about 20 nm, which is basically consistent with the particle size measured by a nanoparticle size potential analyzer.
[0050] The preparation method of guaiazulene liposomes in Comparative Example 1 is the same as that in Example 1 except that caprylic / capric triglyceride is replaced by octyldodecanol.
[0051] The preparation method of guaiazulene liposomes in Comparative Example 2 is the same as that in Example 1 except that kavalactone is replaced by limnanthes lactone.
[0052] The preparation method of guaiazulene liposomes in Comparative Example 3 is the same as that in Example 1.
[0053] The preparation method of guaiazulene liposomes in Comparative Example 4 is the same as that in Example 1 except that benzotriazolyl dodecyl p-cresol is replaced by bis-ethylhexyloxyphenol methoxyphenyl triazine.
[0054] The preparation method of guaiazulene liposomes in Comparative Example 5 is the same as that in Example 1 except that pentaerythritol tetra(di-tert-butylhydroxyhydrocinnamate) is replaced by tocopherol acetate.
[0055] The method for preparing guaiazulene liposomes in Comparative Example 6 is the same as that in Example 1 except that troxerutin is replaced by pentaerythritol tetra(di-tert-butylhydroxyhydrocinnamate).
[0056] The method for preparing guaiazulene liposomes in Comparative Example 7 is the same as that in Example 1 except that tris(tetramethylhydroxypiperidinol) citrate is replaced by troxerutin.
[0057] Comparative Example 8 is a guaiacylglycerol oil solution, which is prepared by stirring and dissolving 95 parts of caprylic / capric triglyceride and 5 parts of guaiacylglycerol.
[0058] Comparative Example 9 is the guaiazulene liposome obtained in Example 4 of the prior application CN118286155A, and the preparation method is as follows: S1: 4% guaiazulene, 5% caprylic / capric triglyceride, 2% VC-IP, 1% A alcohol derivative (composed of retinol retinoic acid ester, retinol palmitate, and retinol propionate in a mass ratio of 1:0.5:0.75) and 2% VE derivative (composed of tocopherol acetate and tocopherol glucoside in a mass ratio of 1:0.5) are heated in a water bath at 40°C, and stirred and dissolved at a rate of 800rpm under an inert atmosphere to obtain phase A; S2: 5% soybean lecithin, 2% hexyldecanol, 3% octyldodecanol, and 40% glycerol are heated in a water bath at 60°C at a rate of 15000r pm is dispersed and dissolved, and then kept in a water bath at 60°C to obtain phase B; S3: 0.1% aloesin, 3% hydrogenated phosphatidylcholine, 5% panthenol and the remainder of ultrapure water are magnetically stirred and dissolved and dispersed at a rate of 400rpm at room temperature to obtain phase C; S4: Phase A obtained from S1, Phase B obtained from S2 and Phase C obtained from S3 are mixed and sheared and homogenized at a rate of 15000rpm to obtain a mixed colostrum; S5: The mixed colostrum obtained from S4 is subjected to ultra-high pressure homogenization at a pressure of 25000psi to obtain an active ingredient sub-nano emulsion; S6: The active ingredient sub-nano emulsion obtained from S5 is subjected to microfluidization homogenization at a pressure of 25000psi, and finally treated by a series of liposome extruders to obtain guaiacyl liposomes.
[0059] Test Example 1 In vitro skin retention performance
[0060] The skin retention performance of ex vivo pig skin was tested with reference to GB / T 27818-2011 "In vitro test method for skin absorption of chemicals". The vertical Franz diffusion cell method was used to test the skin retention performance of ex vivo pig skin. The ventral and dorsal abdominal skin of healthy ex vivo Bama pigs aged 1 month stored at -20°C (average thickness of about 750 μm) was taken and thawed naturally at room temperature. After being gently wiped clean with a phosphate buffer solution of pH 6.8-7.4, the initial transepidermal water loss value of the skin was measured with a transepidermal water loss meter. The initial transepidermal water loss value was <15 g / m 2 h, the stratum corneum of the skin is considered intact. A vertical (Franz) diffusion cell is used as the diffusion device. The prepared ex vivo skin is fixed between the supply cell and the receiving cell, with the stratum corneum of the skin facing the supply cell and the dermis facing the receiving cell. 8 mL of phosphate buffer is added to the receiving cell to make the skin in close contact with the receiving solution without bubbles. The transdermal diffusion experiment instrument is turned on, the water level in the water tank is checked, the speed is set to 350 rpm, the temperature to 32°C, and preheated for 5 minutes in advance.
[0061] In each sample test group, 0.2g / cm 2 The guaiazulene liposomes of Examples 1-3, Comparative Examples 1-7, and Comparative Example 9 + 100 mg FITC (fluorescein isothiocyanate) and the guaiazulene oil solution of Comparative Example 8 + 100 mg FITC were added respectively; the diffusion cell was removed at 1 h, the excess sample in the supply cell was discarded, and the skin surface was cleaned with ultrapure water, the tissue block of the effective penetration part in the middle of the skin was removed and fixed in a tissue fixative and frozen, and the tissue section was observed under a fluorescence microscope for the distribution of FITC fluorescence signal in the skin tissue (the photo of the guaiazulene liposomes of Example 1 is shown in FIG. Figure 3 shown);
[0062] Then it was transferred to a high-throughput tissue grinder and fully ground into a skin homogenate. 1 mL of acetonitrile was added for extraction. After standing and filtering, a PursuitXRs C18 (500 g / 3 L) liquid chromatography column was used. The mobile phase was a mixed solution of water and acetonitrile (volume ratio of 45:55), the flow rate was 0.3 mL / min, the injection volume was 20 μL, the column temperature was 30 ° C, the chromatography time was 15 min, and the quantitative detection wavelength was 305 nm. The retention amount of guaiacylamine in the skin was calculated. The results are shown in Table 3.
[0063] Table 3
[0064]
[0065] As can be seen from Table 3, the retention amount of guaiazulene nanoliposomes of Examples 1-3 entering the skin after 1 hour is increased by 37.5-38.8% compared with the guaiazulene oil solution of Comparative Example 8; the guaiazulene nanoliposomes of Examples 1-3 have excellent permeation-enhancing performance; the permeation-enhancing properties of the guaiazulene nanoliposomes of Comparative Examples 1-7 and Comparative Example 9 are decreased to varying degrees compared with the guaiazulene nanoliposomes of Example 1.
[0066] Test Example 2 Stability Performance
[0067] 1. Temperature stability
[0068] The guaiazulene content in the guaiazulene nanoliposomes of Examples 1-3, Comparative Examples 1-7, Comparative Example 9 and the guaiazulene oil solution of Comparative Example 8 prepared on the first day was determined by HPLC; the guaiazulene contents were stored at 4°C, 25°C, and 45°C, respectively, away from light. After 4 weeks, the guaiazulene content was determined. The ratio of the two was the retention rate of the guaiazulene nanoliposomes under different storage conditions. The results are shown in Table 4.
[0069] 2. Light stability
[0070] The guaiazulene content in the guaiazulene nanoliposomes of Examples 1-3, Comparative Examples 1-7, Comparative Example 9 and the guaiazulene oil solution of Comparative Example 8 prepared on the first day was determined by HPLC; the samples were stored at 25°C under natural light for 4 weeks, and the guaiazulene content was determined. The ratio of the two values was the retention rate of the guaiazulene nanoliposomes under different storage conditions; and the guaiazulene nanoliposomes were observed to see if they changed color. The results are shown in Table 4.
[0071] Table 4
[0072]
[0073] As can be seen from Table 4, the retention rate of the guaiazulene nanoliposomes of Examples 1-3 under 45°C and light conditions is still as high as more than 97%, and there is no discoloration after being placed under light conditions for 4 weeks, indicating that the guaiazulene nanoliposomes of Examples 1-3 of the present invention have excellent thermal stability and photostability; the guaiazulene nanoliposomes of Comparative Examples 4-7 and Comparative Example 9 not only have a decreased retention rate under 45°C and light conditions, but also have discoloration, indicating that the present invention only when benzotriazolyl dodecyl p-cresol, tris (tetramethylhydroxypiperidinol) citrate, troxerutin and pentaerythritol tetra (di-tert-butyl hydroxyhydrocinnamic acid) ester are compounded, the obtained guaiazulene nanoliposomes have excellent thermal stability and photostability.
[0074] Test Example 3 Antioxidant Performance
[0075] The guaiazulene nanoliposomes of Examples 1-3, Comparative Examples 1-7, and Comparative Example 9 prepared on the first day were respectively prepared with water to prepare sample solutions with a concentration of 0.1wt%, and the guaiazulene oil solution of Comparative Example 8 prepared on the first day was prepared with 95% ethanol to prepare a sample solution with a concentration of 0.1wt%. The scavenging ability of the test samples for DPPH free radicals was determined according to T / SHRH 006-2018 "Cosmetics-Free Radical (DPPH) Scavenging Experimental Method", and the results are shown in Table 5.
[0076] Test Example 4 Soothing Performance
[0077] The guaiazulene nanoliposomes of Examples 1-3, Comparative Examples 1-7, and Comparative Example 9 prepared on the first day were respectively prepared with water to prepare sample solutions with a concentration of 0.1wt%, and the guaiazulene oil solution of Comparative Example 8 prepared on the first day was prepared with 95% ethanol to prepare a sample solution with a concentration of 0.1wt%. According to the laboratory method (HMC-WI-029 hyaluronidase inhibition rate), the hyaluronidase inhibition ability of the test samples was determined, and the results are shown in Table 5.
[0078] Test Example 5 Skin feel performance: Based on the sensory analysis method in the cosmetics industry.
[0079] A total of 33 volunteers aged 18-40 years, including 15 males and 17 females, were selected as the evaluation team. Each person tried the guaiazulene nanoliposomes of Examples 1-3, Comparative Examples 1-7, and Comparative Example 9 prepared on the first day and the guaiazulene oil solution of Comparative Example 8 prepared on the first day.
[0080] The method of use is as follows: On the back of the hand, a circle with a diameter of about 5 cm is the evaluation area, and the sample volume on the back of the left and right hands is 50 μL each;
[0081] Evaluation index: When using: spreadability; After using: freshness, absorbency and overall preference;
[0082] The arithmetic mean of the evaluation levels of all evaluators in the evaluation group was calculated, and the result was rounded to one decimal place as the skin feel level; the evaluation levels were divided into four levels: level 1 was poor; level 2 was average; level 3 was relatively satisfactory; and level 4 was very satisfactory; the results are shown in Table 5.
[0083] Table 5
[0084]
[0085] As can be seen from Table 5, the DPPH clearance rate of the guaiacylglycerol nanoliposomes of Examples 1-3 is 61.3-63.5%, the hyaluronidase inhibition rate is 65.4-66.8%, and the skin feel grade is 3.5-3.8, that is, it has good antioxidant, soothing and skin feel; in Comparative Example 1, since caprylic / capric triglyceride is replaced with octyldodecanol, the skin feel grade of the guaiacylglycerol nanoliposomes is reduced to 2.1; in Comparative Example 2, kavalactone is replaced with white meadowfoam lactone, and the hyaluronidase inhibition rate can only reach 55.1%; the antioxidant, soothing and skin feel of other comparative examples are also reduced to varying degrees compared with Example 1.
[0086] Finally, it should be noted that the above content is only used to illustrate the technical solution of the present invention, rather than to limit the scope of protection of the present invention. Simple modifications or equivalent substitutions of the technical solution of the present invention by ordinary technicians in this field do not deviate from the essence and scope of the technical solution of the present invention.
Claims
1. A guaiazulene liposome, It is characterized in that Ingredients include: Glycerin, liquid lipids, glycols, guaiacyl ether, phospholipids, tocopheryl acetate, kavalactones, stabilizers and purified water.
2. The guaiazulene liposome according to claim 1, It is characterized in that The guaiazulene liposome comprises, by weight, 30-40 parts of glycerol, 20-35 parts of liquid oil, 8-15 parts of diol, 1-5 parts of guaiazulene, 1-5 parts of phospholipids, 1-2 parts of tocopherol acetate, 0.1-1 parts of kavalactone, 0.005-0.008 parts of stabilizer and 1-35 parts of purified water.
3. The guaiazulene liposome according to claim 2, It is characterized in that The mass ratio of guaiazulene to kavalactone is 5:
1.
4. The guaiazulene liposome according to claim 3, It is characterized in that The guaiazulene liposomes include, by weight, 30 parts of glycerol, 20 parts of liquid oil, 9.935 parts of diol, 5 parts of guaiazulene, 1 part of phospholipid, 1 part of tocopherol acetate, 1 part of kavalactone, 0.0065 parts of stabilizer and 32.0585 parts of purified water.
5. The guaiazulene liposome according to any one of claims 1 to 4, It is characterized in that The stabilizer includes benzotriazolyl dodecyl p-cresol, tris(tetramethylhydroxypiperidinol) citrate, troxerutin and pentaerythritol tetra(di-tert-butylhydroxyhydrocinnamate).
6. The guaiazulene liposome according to claim 5, It is characterized in that The mass ratio of the benzotriazolyl dodecyl p-cresol, tris(tetramethylhydroxypiperidinol) citrate, troxerutin and pentaerythritol tetra(di-tert-butylhydroxyhydrocinnamate) ester is 0.8-1.2:14-16:2-4:0.8-1.
2.
7. The guaiazulene liposome according to claim 6, It is characterized in that The particle size of the guaiazulene liposome is ≤30 nm.
8. A method for preparing the guaiazulene liposome according to any one of claims 1 to 7, It is characterized in that The following steps are involved: Heat and dissolve guaiazulene, kava lactone, liquid oil and tocopherol acetate to obtain phase A; dissolve the stabilizer in diol to obtain phase B; add phase B to phase A, then add glycerol, phospholipids and purified water and heat and dissolve to obtain phase C; The C phase is subjected to high shear homogenization treatment to obtain a micron-sized crude emulsion; and the micron-sized crude emulsion is subjected to microfluidization high-pressure homogenization treatment to obtain guaiacyl liposomes.
9. The preparation method according to claim 8, It is characterized in that The conditions of the high shear homogenization treatment are: stirring speed of 6000-8000 rpm, and stirring time of 10-15 min.
10. Use of the guaiazulene liposome according to any one of claims 1 to 7 in preparing a transparent skin care product, It is characterized in that The transparent system skin care products include water-based skin care products and / or essence-based skin care products.
Citation Information
Patent Citations
Triazine derivatives
CN101443319A
Super-nano wrapping system and preparation method thereof
CN118286155A
Blanking aperture array system and multi-charged particle beam writing apparatus
KR1020240011626A
Method for the server operates, providing price comparisons and discount information on products of interest
KR1020250148808A
Skin care compositions containing retinoids and liposomes
WO1996031194A2
Cited By
Wrinkle-removing and anti-aging composition containing vermilion as well as preparation method and application of wrinkle-removing and anti-aging composition
CN120267550A
A spilanthol-containing anti-wrinkle and anti-aging composition, and a preparation method and application thereof
CN120267550B
Lipoic acid liposome as well as preparation method and application thereof
CN121243036A
Liposome of lipoic acid, and preparation method and application thereof
CN121243036B
